Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer

Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

William Pao, Vincent A. Miller, Katerina Politi et al. · PLoS Medicine · 2005 · 3.5K citations · Full text

Medicine, Oncology, Pharmacology +17

Epidermal Growth Factor Receptor in Non–Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on Prognosis

Fred R. Hirsch, Marileila Varella‐Garcia, Paul A. Bunn et al. · Journal of Clinical Oncology · 2003 · 1.5K citations

Medicine, Genetics, Oncology +17

Chapter 12 Monitoring Autophagic Degradation of p62/SQSTM1

Geir Bjørkøy, Trond Lamark, Serhiy Pankiv et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 2009 · 1.1K citations

Life Sciences, Biochemistry, Cell Biology +11

The Atg12-Atg5 Conjugate Has a Novel E3-like Activity for Protein Lipidation in Autophagy

Takao Hanada, Nobuo N. Noda, Yoshinori Satomi et al. · Journal of Biological Chemistry · 2007 · 1.1K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12

Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib

Eunice L. Kwak, Raffaella Sordella, Daphne W. Bell et al. · Proceedings of the National Academy of Sciences · 2005 · 952 citations

Medicine, Medicinal Chemistry, Pharmacology +13